Skip to main content
. Author manuscript; available in PMC: 2017 Apr 28.
Published in final edited form as: Circulation. 2012 Dec 12;127(1):e6–e245. doi: 10.1161/CIR.0b013e31828124ad

Table 21-3.

Time Trends in GWTG-ACS Quality-of-Care Measures, 2006–2011

Quality-of-Care Measure 2006 2007 2008 2009 2010* 2011*
Aspirin within 24 h of admission 94.7 92.8 91.2 90.9 97 97.6
Aspirin at discharge 94.4 95.8 94.9 95.5 98 98.3
β-Blockers at discharge 92.8 94.6 94.5 94.9 96 96.7
Lipid-lowering medication at discharge 84.5 85.6 81.6 86.8 92 98.4
Lipid therapy at discharge if LDL cholesterol >100 mg/dL 89.1 90.7 91.9 92.5 NM NM
ARB/ACEI at discharge for patients with LVEF <40% 87.3 91.1 91.9 91.9 86 87.8
Adult smoking cessation advice/counseling 94.3 97.4 98.4 98.4 98 98.4
Cardiac rehabilitation referral for AMI patients 71.1 63.6 52.0 49.1 75 76.5

Values are percentages.

In the ACTION registry (Acute Coronary Treatment and Intervention Outcomes Registry), the unadjusted in-hospital mortality rate for 2011 was 4.6% (95% confidence interval, 4.4%–4.7%); excludes transfer-out patients). The American Heart Association’s (AHA’s) GWTG-CAD has now merged into the ACTION registry.

GWTG-ACS indicates Get With The Guidelines–Acute Coronary Syndrome; LDL, low-density lipoprotein; NM, not measured; ARB/ACEI, angiotensin receptor blocker/ angiotensin-converting enzyme inhibitor; LVEF, left ventricular ejection fraction; and AMI, acute myocardial infarction.

*

Measures from 2006–2009 are from the AHA’s GWTG-CAD (Coronary Artery Disease) registry. 2010/2011 measures are from the AHA’s ACTION registry (Acute Coronary Treatment and Intervention Outcomes Registry.

Represents statin use.